India, which has 61.26 million people diagnosed with type 2 diabetes (8.3 percent of the population), ranks second only to China in total cases and third behind the United States (10.9 percent) and China in terms of prevalence. By 2030, India will have 101.2 million people with type 2 diabetes, IDF projects. “In keeping with a long legacy of addressing global health issues through innovative and sustainable philanthropic programs, Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are pleased to expand our philanthropic work in type 2 diabetes to India and China, where the disease has become a significant public health concern,” said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb.
“As their populations grow older and more sedentary, health authorities in India and China are seeing many of the same problems experienced by their Western counterparts, namely obesity and type 2 diabetes,” said John Damonti, president, Bristol-Myers Squibb Foundation and vice president, Corporate Philanthropy, Bristol-Myers Squibb. “What’s worse, we are seeing only the tip of the iceberg. For every patient in India or China who has been diagnosed with type 2 diabetes, there are several others who are undiagnosed or considered pre-diabetic.
Together on Diabetes is a model developed in the United States, that aims to improve health outcomes of people living with type 2 diabetes by strengthening patient self-management education, community-based supportive services and broad-based community mobilization. In line with the Bristol-Myers Squibb Foundation’s mission to reduce health disparities, Together on Diabetes targets populations disproportionately affected by type 2 diabetes. After a successful launch in the United States, Bristol- Myers Squibb and the Bristol-Myers Squibb Foundation extended Together on Diabetes® to India and China to help address the growing public health issue and focus on the increased incidence of Cardiovascular/
In 2012 Bristol-Myers Squibb celebrates its 125th anniversary of the company’s founding; and the Bristol-Myers Squibb Foundation marks its 5th anniversary of its Delivering Hope® initiative to address hepatitis B and C in India.